Background: Cerebral metabolic monitoring ill critical neurological pa
tients allows the assessment of neuronal tissue response to injury and
to plan the best therapy? to correct each critical brain situation. A
im: To evaluate the usefulness of cerebral metabolic monitoring ill pa
tients with, acute cerebral injury. Patients and methods: A retrospect
ive analysis of 29 patients with acute brain injury in whom a catheter
was located in the bulb of the jugular vein to perform a cerebral met
abolic monitoring. These patients were compared with others that were
not subjected to this monitoring. The evolution at six months of follo
w lip was assessed using the Glasgow outcome score, considering a favo
rable evolution when this score was 4 or ,greater. Results: Patients w
ith all hyperemic state on admission after optimisation Of therapy did
not have hospital mortality: and 73% had Glasgow outcome score of 4 o
i. greater nt six months of follow up. On the other hand 50% of those
with hypoperfusion or global ischemia died during hospitalization and
72% had a Glasgow outcome score of 3 ol less at six months. Patients n
ot subjected to cerebral metabolic monitoring behave as those with hyp
operfusion; or-global ischemia. Conclusions: Cerebral metabolic monito
ring is an useful tool to optimize the management of patients with acu
te cerebral injury, and those Patients with all hyperemic cerebral sta
te have the best prognosis.